Novo Nordisk A/S's (NOVO-B.KO) diabetes treatment Victoza has had a positive reception since it was launched on a number of European markets in July, Chief Executive Lars Rebien Sorensen said at a conference call Thursday, following the Danish pharmaceutical company's second-quarter report , Wall Street Journal reports.
However, the world's top supplier of insulin said net profit in April through June reached almost 3 billion kroner ($580 million), up from about 2.5 billion kroner in the same period in 2008. Sales increased to 13 billion kroner from 11.1 billion kroner , Los Angeles Times reports.
Meanwhile, his remarks came after the company said in its second-quarter earnings report that it was in a "constructive dialogue" with the FDA on Victoza.
Brandgaard said that the global insulin markets were growing more slowly than the company previously expected , Reuters reports.
Subscribe to Pravda.Ru Telegram channel, Facebook, Twitter, YouTube, RSS!
Eyewitnesses said that explosions could be heard in the centre of Kyiv. Smoke was seen rising above Zhuliany Airport (Kyiv International Airport)